RIVERHEAD CAPITAL MANAGEMENT LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 284 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$358,000
-41.0%
19,650
+15.2%
0.01%
-40.9%
Q2 2019$607,000
-20.7%
17,050
-25.1%
0.02%
-29.0%
Q1 2019$765,000
-69.6%
22,765
-70.3%
0.03%
-72.6%
Q4 2018$2,519,000
-33.5%
76,632
+23.2%
0.11%
-17.5%
Q3 2018$3,790,000
+989.1%
62,177
+771.6%
0.14%
+878.6%
Q2 2018$348,000
+56.8%
7,134
+241.0%
0.01%
+55.6%
Q1 2018$222,000
-69.5%
2,092
-82.8%
0.01%
-71.0%
Q4 2017$727,000
+200.4%
12,177
+20.8%
0.03%
+181.8%
Q3 2017$242,000
+41.5%
10,077
+15.1%
0.01%
+37.5%
Q2 2017$171,000
+48.7%
8,754
+78.7%
0.01%
+33.3%
Q1 2017$115,000
+113.0%
4,900
+11.4%
0.01%
+100.0%
Q4 2016$54,000
-28.9%
4,4000.0%0.00%
-40.0%
Q3 2016$76,000
-89.4%
4,400
-92.7%
0.01%
-54.5%
Q2 2016$716,000
+85.0%
59,972
+113.0%
0.01%
+120.0%
Q1 2016$387,000
-21.0%
28,154
-3.3%
0.01%
-28.6%
Q4 2015$490,000
+390.0%
29,100
+219.8%
0.01%
+250.0%
Q3 2015$100,0009,1000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2019
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders